- Home
- ARTV vs CBAN Comparison
ARTV vs CBAN Comparison
Compare ARTV & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTV
- CBAN
- Stock Information
- Founded
- ARTV 2019
- CBAN 1975
- Country
- ARTV United States
- CBAN United States
- Employees
- ARTV N/A
- CBAN N/A
- Industry
- ARTV
- CBAN Major Banks
- Sector
- ARTV
- CBAN Finance
- Exchange
- ARTV NYSE
- CBAN Nasdaq
- Market Cap
- ARTV 232.8M
- CBAN 229.6M
- IPO Year
- ARTV 2024
- CBAN 1998
- Fundamental
- Price
- ARTV $11.79
- CBAN $15.73
- Analyst Decision
- ARTV Strong Buy
- CBAN
- Analyst Count
- ARTV 5
- CBAN 0
- Target Price
- ARTV $21.25
- CBAN N/A
- AVG Volume (30 Days)
- ARTV 79.3K
- CBAN 33.1K
- Earning Date
- ARTV 08-29-2024
- CBAN 10-23-2024
- Dividend Yield
- ARTV N/A
- CBAN 2.90%
- EPS Growth
- ARTV N/A
- CBAN 5.35
- EPS
- ARTV N/A
- CBAN 1.26
- Revenue
- ARTV $29,256,000.00
- CBAN $109,415,000.00
- Revenue This Year
- ARTV N/A
- CBAN N/A
- Revenue Next Year
- ARTV N/A
- CBAN $6.75
- P/E Ratio
- ARTV N/A
- CBAN $12.44
- Revenue Growth
- ARTV 493.31
- CBAN N/A
- 52 Week Low
- ARTV $9.71
- CBAN $9.36
- 52 Week High
- ARTV $16.00
- CBAN $15.89
- Technical
- Relative Strength Index (RSI)
- ARTV N/A
- CBAN 75.05
- Support Level
- ARTV N/A
- CBAN $15.35
- Resistance Level
- ARTV N/A
- CBAN $15.89
- Average True Range (ATR)
- ARTV 0.00
- CBAN 0.40
- MACD
- ARTV 0.00
- CBAN 0.05
- Stochastic Oscillator
- ARTV 0.00
- CBAN 96.06
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.
About CBAN Colony Bankcorp Inc.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division, and small business specialty lending divisions. It generates maximum revenue from the Banking Division.